Manzo Pharmaceuticals, Inc.
MNZO · OTC
12/31/2015 | 12/31/2014 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $11 | $10 | $12 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1,444 |
| Other Curr. Assets | $0 | $0 | $138 | $141 |
| Total Curr. Assets | $12 | $11 | $148 | $1,598 |
| Property Plant & Equip (Net) | $0 | $0 | $1,142 | $1,286 |
| Goodwill | $110 | $0 | $0 | $0 |
| Intangibles | $70 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $2,108 |
| Total NC Assets | $180 | $0 | $1,142 | $3,394 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $192 | $11 | $1,290 | $4,991 |
| Liabilities | – | – | – | – |
| Payables | $0 | $17 | $405 | $433 |
| Short-Term Debt | -$11 | $89 | $6,523 | $7,315 |
| Tax Payable | $0 | $0 | $1,487 | $2,145 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $73 | $15,379 | $13,562 |
| Total Curr. Liab. | -$11 | $179 | $23,793 | $23,455 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | -$11 | $179 | $23,793 | $23,455 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $4 | $0 | $0 |
| Common Stock | $1,160 | $465 | $35 | $0 |
| Retained Earnings | -$12,403 | -$3,804 | -$31,371 | -$27,220 |
| AOCI | $0 | $0 | -$24 | -$15 |
| Other Equity | $11,424 | $3,168 | $8,857 | $8,772 |
| Total Equity | $181 | -$168 | -$22,503 | -$18,464 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $170 | $11 | $1,290 | $4,991 |
| Net Debt | -$23 | $79 | $6,513 | $7,303 |